Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction
Public ClinicalTrials.gov record NCT07115056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial
Study identification
- NCT ID
- NCT07115056
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Campbell Clinic
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Tranexamic Acid (TXA) Drug
Drug
Eligibility (public fields only)
- Age range
- 14 Years to 22 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026
- Primary completion
- Dec 30, 2028
- Completion
- Dec 30, 2029
- Last update posted
- Mar 2, 2026
2026 – 2029
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endeavor Health | Evanston | Illinois | 60201 | — |
| Washington University School of Medicine in St. Louis | Chesterfield | Missouri | 63017 | — |
| Duke University School of Medicine | Durham | North Carolina | 27705 | — |
| University of Cincinnati | Cincinnati | Ohio | 45221 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15260 | — |
| Campbell Clinic | Germantown | Tennessee | 38138 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07115056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07115056 live on ClinicalTrials.gov.